December 15, 2025 — Synopsys, Inc. (NASDAQ: SNPS) is back in the spotlight as investors weigh a fast-moving mix of catalysts: a fresh wave of upward earnings-estimate revisions, post-earnings re-rating debate after the company’s latest guidance, the strategic implications of NVIDIA’s $2 billion equity investment, and renewed attention on a securities class action deadline later this month. [1]
As of 19:02 UTC on Monday, Dec. 15, 2025, Synopsys shares traded around $460.04, up roughly 1.6% on the day, after moving between $452.11 and $470.39.
What’s happening with Synopsys stock on Dec. 15, 2025?
Today’s Synopsys coverage clusters around three themes:
- Earnings revisions turning more bullish: A Zacks commentary published midday points to a sharp near-term improvement in consensus earnings expectations, a signal many quant and fundamental investors watch closely. [2]
- The market’s ongoing digestion of FY2026 guidance: Synopsys’ latest quarterly report and outlook (released after the close on Dec. 10) remain the main driver of how analysts are updating price targets and models this week. [3]
- Legal headlines resurfacing the September shock: Multiple law-firm notices published today highlight an upcoming Dec. 30, 2025 deadline tied to a securities class action connected to Synopsys’ steep one-day selloff in September. [4]
The big fundamental driver: Synopsys’ FY2025 results and FY2026 outlook
Synopsys’ most important “hard data” catalyst this month is still its fourth-quarter and fiscal-year 2025 report (fiscal year ended Oct. 31, 2025, disclosed via an 8-K). [5]
Key reported highlights include:
- FY2025 revenue:$7.054 billion (record full-year revenue, per the company). [6]
- Q4 FY2025 revenue:$2.255 billion, slightly above the midpoint of Synopsys’ guidance range. [7]
- Backlog:$11.4 billion cited as a key indicator of demand durability. [8]
- Ansys contribution: management cited $667.7 million added to Q4 revenue and $756.6 million added to FY2025 revenue from Ansys. [9]
FY2026 guidance: growth story now depends on execution, not just demand
For FY2026, Synopsys guided to:
- Revenue:$9.56B to $9.66B (midpoint ~$9.61B), including an expectation of about $2.9B from Ansys. [10]
- Non-GAAP EPS:$14.32 to $14.40 (with multiple outlets highlighting that the EPS outlook was ahead of many expectations even as revenue came in slightly mixed versus some forecasts). [11]
That combination—solid EPS framing alongside a more debated revenue trajectory—is why the stock action immediately after earnings was strong, but then choppy. Barron’s described the move as giving back some post-earnings gains, underscoring that “timing” and broader tech tape can matter as much as the report itself. [12]
“Estimate revisions” are improving again—why that matters today
One of the most-circulated Synopsys items on Dec. 15 is a Zacks analysis distributed via FINVIZ, arguing that upward estimate revisions often correlate with near-term price strength.
Notable data points cited in that analysis:
- Current-quarter consensus EPS estimate referenced: $3.38. [13]
- Zacks reports the consensus estimate rising 16.53% over the past 30 days (with one upward revision and no downward revisions in that window, per the piece). [14]
- Zacks places Synopsys at Rank #2 (Buy) in its rating system (while describing its long-term performance claims for Rank #1). [15]
Investors don’t need to “agree” with Zacks methodology to appreciate what this signals: analysts are actively moving numbers up, which can support valuation even if macro sentiment is mixed.
The NVIDIA–Synopsys partnership: a $2B vote of confidence (with strings attached)
A second major “current” catalyst—still very much in play two weeks later—is Synopsys’ expanded strategic partnership with NVIDIA, announced Dec. 1, 2025.
Two elements matter most for SNPS shareholders:
1) NVIDIA invested $2 billion in Synopsys common stock
Synopsys’ press release states NVIDIA invested $2 billion in Synopsys at a purchase price of $414.79 per share. [16]
At that price, the investment implies roughly 4.8 million shares (simple arithmetic). With SNPS near $460 today, the stock is about 11% above NVIDIA’s stated purchase price. [17]
Reuters characterized the move as part of NVIDIA’s broader dealmaking push around the AI ecosystem and noted the initial market pop in SNPS on the announcement. [18]
2) The partnership is designed to move engineering workloads onto GPU acceleration
Synopsys describes the collaboration as spanning CUDA accelerated computing, “agentic and physical AI,” and Omniverse digital twins, with initiatives to accelerate Synopsys applications (EDA, verification, simulation, and more), advance agentic AI workflows, and broaden access through cloud-ready solutions. [19]
Strategically, this matters because Synopsys is no longer “just” an EDA vendor in the investor narrative. Post-Ansys, the market increasingly prices it as a silicon-to-systems engineering platform—and GPU acceleration is a credible lever to expand both product capability and addressable market.
The Ansys deal is now real—and the 2026 integration timeline is a catalyst
Synopsys’ acquisition of Ansys (announced Jan. 16, 2024) closed on July 17, 2025, per Synopsys’ own announcement. [20]
In that release, Synopsys highlighted:
- A combined opportunity across an expanded $31 billion total addressable market (TAM) (management estimate). [21]
- Plans to deliver a first set of integrated capabilities in the first half of 2026, including multiphysics across the EDA stack and multi-die advanced packaging. [22]
This is a critical framing for SNPS stock into 2026: investors are likely to demand tangible “integration proof points,” not just synergy targets.
Analyst forecasts and price targets: where Wall Street is clustering
After the Dec. 10 earnings report, multiple banks updated targets and ratings. The direction is broadly constructive, but not uniform—an important nuance for readers who want more than a “buy/hold” headline.
Notable target changes reported in the past week
- KeyBanc: raised price target to $600, citing increased confidence in execution and explicitly referencing a 35x P/E multiple framework in its note (as reported by Investing.com). [23]
- BofA Securities: upgraded Synopsys to Buy and raised its price target to $560 (with commentary around “catch-up potential” and reduced perceived risk in certain areas). [24]
- Morgan Stanley: raised its target to $550 (per Investing.com coverage). [25]
- Wells Fargo: maintained an Equal-Weight stance and raised its target to $500, while also publishing multi-year revenue/EPS estimates in its model update (as reported by Investing.com). [26]
- Needham: raised its target to $580 (as summarized in post-earnings analyst roundups). [27]
Where the consensus sits now
Aggregated data sources show a wide range of one-year targets, reflecting uncertainty around the pace of core EDA growth, Ansys integration benefits, and Design IP trajectory:
- StockAnalysis lists an average target around $566 with a spread from roughly $425 to $650 across analysts it tracks. [28]
- Nasdaq/Fintel-style summaries published in early December cite an average near $559 with a range roughly $429 to $662 (depending on the compilation date and coverage universe). [29]
The key takeaway for Dec. 15 readers: the “center of gravity” for targets is mid-$500s, while the tails are still wide—typical for a stock in the middle of a major business mix shift (Ansys) plus a still-debated IP segment reset.
The risk investors can’t ignore: class action deadline coverage resurfaces
Alongside the bullish estimate-revision narrative, Dec. 15 also brings a less comfortable headline: law firms and wire services are amplifying a securities class action tied to Synopsys’ Design IP performance and disclosures during a defined period.
- Rosen Law Firm describes a class period from Dec. 4, 2024 to Sept. 9, 2025, with a motion deadline to seek lead plaintiff status of Dec. 30, 2025. [30]
- A GlobeNewswire notice dated Dec. 15, 2025 references the same Dec. 30 timing and connects the complaint narrative to Synopsys’ September 2025 disclosures around IP underperformance. [31]
Importantly, these are allegations, not proven findings. But the market impact underlying the legal storyline was real: the GlobeNewswire notice cites a drop of nearly 36% from about $604 to $388 across Sept. 9–10, 2025 in the wake of the company’s statements about its IP business. [32]
For investors, the practical question is not “who wins in court” (that can take years), but whether legal noise becomes an overhang that affects valuation multiples, executive focus, or disclosure practices in the near term.
Workforce restructuring: cost discipline meets integration reality
Synopsys’ cost actions are another thread investors are tracking—especially now that Ansys is inside the financials.
A Synopsys 8-K dated Nov. 9, 2025 describes a restructuring plan expected to result in the termination of approximately 10% of Synopsys’ workforce, with estimated pre-tax charges of $300 million to $350 million and an expectation that the plan would be substantially completed by the end of fiscal year 2027 (subject to local requirements). [33]
Reuters also linked the workforce move to reallocating resources toward AI and system-level innovations and noted that Ansys’ contribution materially lifted reported revenue in the latest quarter. [34]
What to watch next for SNPS investors
Looking beyond today’s price tick, the next “decision points” for Synopsys stock are becoming clearer:
- Ansys integration milestones (H1 2026): Synopsys has publicly set expectations for initial integrated capabilities in the first half of 2026—investors will look for product proof points and early commercial traction. [35]
- Follow-through on NVIDIA partnership: The strategic story is powerful, but execution is key—GPU acceleration in EDA and multiphysics workflows is technically complex and commercially consequential. [36]
- Design IP stabilization: The September shock still shapes sentiment, and legal headlines keep the issue visible. Any commentary around pricing models, customization, margin trajectory, and pipeline conversion could move the stock. [37]
- Formal filings and deadlines around Dec. 30, 2025: Synopsys has stated it expects to file its FY2025 10-K on or before Dec. 30, 2025—the same date repeatedly cited in law-firm deadline notices. [38]
Bottom line: Synopsys stock is trading a battle between momentum and memory
Synopsys enters the back half of December with a compelling growth narrative—AI-driven design complexity, an expanded platform after Ansys, and a headline partnership with NVIDIA that includes real capital. [39]
At the same time, the stock is still living with the “memory” of 2025 volatility. Even after today’s bounce, SNPS remains roughly 29% below a cited 52-week high of $651.73 (July 30) from widely circulated market summaries, highlighting how much confidence needs to be rebuilt. [40]
For Dec. 15 readers, the near-term signal is straightforward: analysts are lifting earnings expectations again, and price targets are gravitating higher. But the longer-term verdict on Synopsys stock will hinge on whether management can deliver measurable integration wins, restore durability in Design IP economics, and convert the NVIDIA partnership from a headline into accelerating product and revenue outcomes. [41]
References
1. finviz.com, 2. finviz.com, 3. investor.synopsys.com, 4. www.globenewswire.com, 5. www.sec.gov, 6. investor.synopsys.com, 7. investor.synopsys.com, 8. investor.synopsys.com, 9. investor.synopsys.com, 10. investor.synopsys.com, 11. investor.synopsys.com, 12. www.barrons.com, 13. finviz.com, 14. finviz.com, 15. finviz.com, 16. news.synopsys.com, 17. news.synopsys.com, 18. www.reuters.com, 19. news.synopsys.com, 20. news.synopsys.com, 21. news.synopsys.com, 22. news.synopsys.com, 23. www.investing.com, 24. www.tipranks.com, 25. www.investing.com, 26. www.investing.com, 27. www.benzinga.com, 28. stockanalysis.com, 29. www.nasdaq.com, 30. rosenlegal.com, 31. www.globenewswire.com, 32. www.globenewswire.com, 33. www.sec.gov, 34. www.reuters.com, 35. news.synopsys.com, 36. news.synopsys.com, 37. rosenlegal.com, 38. investor.synopsys.com, 39. news.synopsys.com, 40. www.marketwatch.com, 41. finviz.com
